Document 0328
 DOCN  M9440328
 TI    Treatment of bacterial, fungal, and parasitic infections in the
       HIV-infected host.
 DT    9404
 AU    Berger TG; Department of Dermatology, University of California, San;
       Francisco 94110.
 SO    Semin Dermatol. 1993 Dec;12(4):296-300. Unique Identifier : AIDSLINE
       MED/94145862
 AB    In the human immunodeficiency virus (HIV) infected patient, skin
       infections caused by S aureus are extremely common. Impetigo, ecthyma,
       and folliculitis are all seen. Recurrences are common due to a nasal
       carriage rate of 50%. Dermatophytosis usually manifests as tinea pedis
       or unguium and is caused by Trichophyton rubrum. Oral candidiasis may be
       the initial evidence of HIV infection, and is predictive of more rapid
       progression to acquired immune deficiency syndrome (AIDS). Topical
       agents are usually effective for oral lesions, but involvement of the
       esophagus requires oral imidazole therapy. Systemic fungal infections
       are most commonly caused by cryptococcosis or histoplasmosis. The
       finding of either of these infectious agents in the skin is
       pathognomonic of disseminated infection. Cryptococcus presents as
       umbilicated papules resembling molluscum or as large ulcerations.
       Histoplasmosis has no specific cutaneous morphology. Scabies is very
       common in HIV-infected persons, and once the helper T-cell count is less
       than 200, it may present atypically. Permethrin is the recommended
       treatment in this setting.
 DE    Anti-Infective Agents/*THERAPEUTIC USE  Antifungal Agents/THERAPEUTIC
       USE  Benzene Hexachloride/THERAPEUTIC USE
       Dermatomycoses/COMPLICATIONS/*DRUG THERAPY  Human  HIV
       Infections/*COMPLICATIONS  Insecticides, Botanical/THERAPEUTIC USE
       Pyrethrins/THERAPEUTIC USE  Skin Diseases, Bacterial/COMPLICATIONS/*DRUG
       THERAPY  Skin Diseases, Parasitic/COMPLICATIONS/*DRUG THERAPY  JOURNAL
       ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).